Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”
Intestinal Research · 31.10.2026 · 24 (4) · 813-814
DOI: 10.5217/ir.2026.00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Joaquín Borrás-Blasco und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Sagunto Hospital, Sagunto, Spain. jborrasb@gmail.com. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pharmacy Department, Sagunto Hospital, Sagunto, Spain. jborrasb@gmail.com.
- Pharmacy Department, Hospital Padre Jofre, Valencia, Spain.
- Pharmacy Department, Sagunto Hospital, Sagunto, Spain.
Zitieren
APA
Borrás-Blasco, J., Valcuende-Rosique, A., & Cornejo-Uixeda, S. (2026). Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”. Intestinal Research, 24(4), 813-814. https://doi.org/10.5217/ir.2026.00062
Vancouver
Borrás-Blasco J, Valcuende-Rosique A, Cornejo-Uixeda S. Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”. Intestinal Research. 2026;24(4):813-814. doi:10.5217/ir.2026.00062
BibTeX
@article{BorrsBlasco2026,
author = {Borrás-Blasco, Joaquín and Valcuende-Rosique, Alejandro and Cornejo-Uixeda, Silvia},
title = {Comments on “Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study”},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {4},
pages = {813--814},
doi = {10.5217/ir.2026.00062}
}
EUVIMED